Bristol Myers Squibb (BMY) FCF Margin Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
1,396.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-935.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
1,326.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
1,043.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
511.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
1,008.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
934.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-853.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-853.00 |
| Dec 31, 2025 |
-2,007.00 |
| Sep 30, 2025 |
473.00 |
| Jun 30, 2025 |
1,207.00 |
| Mar 31, 2025 |
-637.00 |
| Dec 31, 2024 |
-127.00 |
| Sep 30, 2024 |
408.00 |
| Jun 30, 2024 |
241.00 |
| Mar 31, 2024 |
-225.00 |
| Dec 31, 2023 |
822.00 |
| Sep 30, 2023 |
954.00 |
| Jun 30, 2023 |
-223.00 |
| Mar 31, 2023 |
-681.00 |
| Dec 31, 2022 |
-523.00 |
| Sep 30, 2022 |
-1,232.00 |
| Jun 30, 2022 |
-762.00 |
| Mar 31, 2022 |
-242.00 |
| Dec 31, 2021 |
342.00 |
| Sep 30, 2021 |
2,292.00 |
| Jun 30, 2021 |
-1,871.00 |
| Mar 31, 2021 |
-182.00 |
| Dec 31, 2020 |
346.00 |
| Sep 30, 2020 |
-1,933.00 |
| Jun 30, 2020 |
1,290.00 |
| Mar 31, 2020 |
1,476.00 |
| Dec 31, 2019 |
-3,037.00 |
| Sep 30, 2019 |
2,085.00 |
| Jun 30, 2019 |
1,510.00 |
| Mar 31, 2019 |
201.00 |
| Dec 31, 2018 |
3,882.00 |
| Sep 30, 2018 |
-908.00 |
| Jun 30, 2018 |
-1,091.00 |
| Mar 31, 2018 |
646.00 |
| Dec 31, 2017 |
-461.00 |
| Sep 30, 2017 |
602.00 |
| Jun 30, 2017 |
2,232.00 |
| Mar 31, 2017 |
2,227.00 |
| Dec 31, 2016 |
647.00 |
| Sep 30, 2016 |
1,447.00 |
| Jun 30, 2016 |
591.00 |
| Mar 31, 2016 |
-2,283.00 |
| Dec 31, 2015 |
502.00 |
| Sep 30, 2015 |
-1,317.00 |
| Jun 30, 2015 |
-2,658.00 |
| Mar 31, 2015 |
-97.00 |
| Dec 31, 2014 |
-1,830.00 |
| Sep 30, 2014 |
-255.00 |
| Jun 30, 2014 |
-1,056.00 |
| Mar 31, 2014 |
2,727.00 |
| Dec 31, 2013 |
1,147.00 |
| Sep 30, 2013 |
-9,618.00 |
| Jun 30, 2013 |
1,190.00 |
| Mar 31, 2013 |
-1,920.00 |
| Dec 31, 2012 |
-1,052.00 |
| Sep 30, 2012 |
8,883.00 |
| Jun 30, 2012 |
423.00 |
| Mar 31, 2012 |
-307.00 |
| Dec 31, 2011 |
-247.00 |
| Sep 30, 2011 |
323.00 |
| Jun 30, 2011 |
-155.00 |
| Mar 31, 2011 |
113.00 |
| Dec 31, 2010 |
595.00 |
| Sep 30, 2010 |
-27.00 |
